Patterns of Failure in Multiple Myeloma with Extramedullary Disease Following Anti-BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy

被引：0
|
作者：
Nakashima, J. Y. [1 ]
Khatri, V. [1 ]
Cruz-Chamorro, R. J. [1 ]
Zhou, J. [2 ]
Patra, P. [2 ]
Gonzalez, R. [3 ]
De Avila, G. [3 ]
Locke, F. L. [3 ]
Liu, H. D. [3 ]
Nishihori, T. [3 ]
Puglianini, O. C. [3 ]
Alsina, M. [3 ]
Garjales-Cruz, A. [4 ]
Baz, R. [4 ]
Shah, B. D. [4 ]
Shain, K. [4 ]
Jain, M. D. [3 ]
Hansen, D. [3 ]
Freeman, C. [3 ]
Figura, N. B. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[2] Univ S Florida, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1121
引用
收藏
页码：S206 / S207
页数：2
相关论文
共 50 条
  • [1] Anti-BCMA CAR T-Cell Therapy in Multiple Myeloma
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03):
  • [2] Anti-BCMA CAR T-cell Therapy Reins in Myeloma
    Dolgin, Elie
    CANCER DISCOVERY, 2019, 9 (07) : 817 - 819
  • [3] CARDIAC EVENTS AFTER ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR T-CELL (IDECABTAGENE VICLEUCEL) FOR MULTIPLE MYELOMA
    Lee, Dae Hyun
    Chandrasekhar, Sanjay Amrith
    Jain, Michael
    Hansen, Doris
    Freeman, Ciara
    Alsina, Melissa
    Baz, Rachid
    Puglianini, Omar Castaneda
    Liu, Hien
    Blue, Brandon
    Davila, Marco L.
    Faramand, Rawan
    Kumar, Abhishek
    Shah, Bijal
    Lazaryan, Aleksandr
    Khimani, Farhad
    Nishihori, Taiga
    Bachmeier, Christina
    Locke, Frederick
    Oliveira, Guilherme Henrique
    Alomar, Mohammed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1933 - 1933
  • [4] Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
    Zhang, Lina
    Shen, Xuxing
    Yu, Wenjun
    Li, Jing
    Zhang, Jue
    Zhang, Run
    Li, Jianyong
    Chen, Lijuan
    ANNALS OF MEDICINE, 2021, 53 (01) : 1547 - 1559
  • [5] The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma
    Manjunath, Shwetha H.
    Cohen, Adam D.
    Lacey, Simon F.
    Davis, Megan M.
    Garfall, Alfred L.
    Melenhorst, J. Joseph
    Maxwell, Russell
    Arscott, W. Tristram
    Maity, Amit
    Jones, Joshua A.
    Plastaras, John P.
    Stadtmauer, Edward A.
    Levine, Bruce L.
    June, Carl H.
    Milone, Michael C.
    Paydar, Ima
    CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6580 - 6590
  • [6] Anti-BCMA CAR T-cell Therapy: Changing the Natural History of Multiple Myeloma
    Puertas, Borja
    Mateos, Maria-Victoria
    Gonzalez-Calle, Veronica
    HEMASPHERE, 2022, 6 (03):
  • [7] Outcomes of BCMA-Directed Chimeric Antigen Receptor T-Cell (CART) Therapy in Patients with Relapse-Refractory Multiple Myeloma with Extramedullary Disease
    Dima, Danai
    Davis, James A.
    Rashid, Aliya
    Rice, Mikhaila
    DeJarnette, Shaun
    Shune, Leyla
    Khouri, Jack
    Raza, Shahzad
    McGuirk, Joseph P.
    Anwer, Faiz
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Hashmi, Hamza
    BLOOD, 2023, 142
  • [8] HBI0101, an Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) for Relapsed/Refractory Multiple Myeloma
    Lebel, Eyal
    Asherie, Nathalie
    Kfir-Erenfeld, Shlomit
    Grisariu, Sigal
    Avni, Batia
    Elias, Shlomo
    Assayag, Miri
    Dubnikov-Sharon, Tali
    Zimran, Eran
    Shaulov, Adir
    Pick, Marjorie
    Cohen, Cyrille
    Stepensky, Polina
    Gatt, Moshe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S22 - S22
  • [9] Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma
    Choi, Taewoong
    Kang, Yubin
    PHARMACOLOGY & THERAPEUTICS, 2022, 232
  • [10] Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Yamamoto, Chihiro
    Minakata, Daisuke
    Yokoyama, Daizo
    Furuki, Shuka
    Noguchi, Atsuto
    Koyama, Shunsuke
    Oyama, Takashi
    Murahashi, Rui
    Nakashima, Hirotomo
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Hyodo, Kazuki
    Toda, Yumiko
    Ito, Shoko
    Nagayama, Takashi
    Umino, Kento
    Morita, Kaoru
    Ashizawa, Masahiro
    Ueda, Masuzu
    Hatano, Kaoru
    Sato, Kazuya
    Ohmine, Ken
    Fujiwara, Shin-ichiro
    Kanda, Yoshinobu
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 118.e1 - 118.e15
12345